263 related articles for article (PubMed ID: 14980688)
21. Design, synthesis and pharmacology of aortic-selective acyl-CoA: Cholesterol O-acyltransferase (ACAT/SOAT) inhibitors.
Shibuya K; Kawamine K; Miura T; Ozaki C; Edano T; Mizuno K; Yoshinaka Y; Tsunenari Y
Bioorg Med Chem; 2018 Aug; 26(14):4001-4013. PubMed ID: 29945757
[TBL] [Abstract][Full Text] [Related]
22. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Tomoda H; Doi T
Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
[TBL] [Abstract][Full Text] [Related]
23. Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitors.
Toma L; Giovannoni MP; Vergelli C; Dal Piaz V; Kwon BM; Kim YK; Gelain A; Barlocco D
Arch Pharm (Weinheim); 2002; 335(11-12):563-6. PubMed ID: 12596221
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and structure-activity relationship studies of novel 4,4-bis(trifluoromethyl)imidazolines as acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents.
Li HY; DeLucca I; Boswell GA; Billheimer JT; Drummond S; Gillies PJ; Robinson C
Bioorg Med Chem; 1997 Jul; 5(7):1345-61. PubMed ID: 9377095
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agents.
Purchase TS; Essenburg AD; Hamelehle KL; Hes MS; Holmes A; Krause BR; Stanfield RL; Trivedi BK
Bioorg Med Chem; 1997 Apr; 5(4):739-47. PubMed ID: 9158873
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
[TBL] [Abstract][Full Text] [Related]
27. Saucerneol B derivatives as human acyl-CoA: cholesterol acyltransferase inhibitors.
Jeong TS; Kim KS; Yu H; Kim MJ; Cho KH; Choi YK; Kim HC; Park HY; Lee WS
Bioorg Med Chem Lett; 2005 Jan; 15(2):385-8. PubMed ID: 15603959
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
Matsui Y; Horiuchi K; Yamamoto K; Kanai K
Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
[TBL] [Abstract][Full Text] [Related]
30. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N'-(1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents.
Asano S; Ban H; Kino K; Ioriya K; Muraoka M
Bioorg Med Chem; 2009 Jul; 17(13):4636-46. PubMed ID: 19464189
[TBL] [Abstract][Full Text] [Related]
32. First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Hu H; Liao H; Zhang J; Wu W; Yan J; Yan Y; Zhao Q; Zou Y; Chai X; Yu S; Wu Q
Bioorg Med Chem Lett; 2010 May; 20(10):3094-7. PubMed ID: 20403694
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2.
Ohtawa M; Yamazaki H; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 May; 23(9):2659-62. PubMed ID: 23535327
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
35. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
[TBL] [Abstract][Full Text] [Related]
36. Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors.
Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
J Med Chem; 2008 Mar; 51(5):1474-7. PubMed ID: 18284184
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets.
Lee HT; Sliskovic DR; Picard JA; Roth BD; Wierenga W; Hicks JL; Bousley RF; Hamelehle KL; Homan R; Speyer C; Stanfield RL; Krause BR
J Med Chem; 1996 Dec; 39(26):5031-4. PubMed ID: 8978833
[No Abstract] [Full Text] [Related]
38. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
Adameová A; Kuzelová M; Faberová V; Svec P
Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
[TBL] [Abstract][Full Text] [Related]
39. Amides of piperidine, morpholine and piperazine substituted 1-phenylethylamines: inhibitors of acylCoA:cholesterol acyltransferase (ACAT) activity in vitro and in vivo.
Dugar S; Davis HR; Burrier RE; Salisbury BG
Bioorg Med Chem; 1995 Sep; 3(9):1231-6. PubMed ID: 8564414
[TBL] [Abstract][Full Text] [Related]
40. Quantitative structure-activity relationship of 4,5-diphenyl-2-(substituted thio)-1H-imidazoles as the inhibitors of acyl CoA: cholesterol acyltransferase.
Singh P; Kumar R
Indian J Biochem Biophys; 1998 Jun; 35(3):179-83. PubMed ID: 9803668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
